Metropolitan Court, Boedapest, Hungary, 2012, Case no's 3.Pk.22.015/2012; 3.Pk.22.013/2012; date June 12, 2012, 3.Pk.22.014/2012, date June 19, 2012, 3.Pk.22.006/2012; 3.Pk.22.007/2012; 3.Pk.22.024/2012, reported by Eszter Szakacs
"Hungary – Six parallel preliminary injunctions in a pharmaceutical patent infringement proceeding
"With the heaviest wave of interim measures ever seen in the history of pharmaceutical patent litigation in Hungary, the Metropolitan Court of Budapest granted six preliminary injunctions in June 2012 at the same time against pharmaceutical companies and wholesalers due to the likely infringement of the patentee’s medical use patent related to a blockbuster product.
"The patentee’ first generation product patent covering the subject compound expired in June 2011, after which several generic competitors launched their own products in Hungary, even though the patentee still had a further pending patent application for a second medical use. Their hopes for the refusal of this application must have been turned down by the grant of this use patent in April 2012, after an extremely long examination period of 18 years, leaving barely two years of market exclusivity for the patentee."
Read the entire summary (in English) here.